We motivate to act
WE INVEST
IN TECHNOLOGY
PHILOSOPHY
Carlson Investments SE, in operation since 2003, is a company listed on the Warsaw Stock Exchange and the Stock Exchanges of Frankfurt, Stuttgart, Munich and on the Gettex platform established to provide access to venture capital investment opportunities in Europe, North America and Asia, with a particular focus on Central and Eastern Europe.
We are open-ended (not limited by timeframe), no need to exit under the pressure of time like standard VCs. Easy access and exit via one of the markets for any even smallest investors. The company has more than 30 promising projects in its portfolio.
Investment objective:
Our purpose is to offer liquid access to venture capital investments, a traditionally illiquid asset class.
Investment policy:
We take equity positions in private companies of a technological nature characterized by-product or process innovation active in the financial, medical, and deep technology industries. Investments are made both directly and through subsidiary AIF Carlson Investments, both authorized and regulated by Polish Financial Supervision Authority (KNF) and /or German BaFin.
Symbol | CAI: WSE, 2HB:FRA 2HB:STU, 2HB:MUC |
ISIN | PLHOTB000011 (WKN:A0RNWQ) |
IPO Date | 2009 On Warsaw Stock Exchange 05.2021 – Dual listing on Boerse Frankfurt (XFRA) 07.2021 – Dual listing on Boerse Stuttgart (SWB) 03.2022 – Dual listing on Boerse Munich (XMUN) 03.2022 – Dual listing GETTEX Exchange (MUNC) |
MERGER OF COMPANIES
Carlson Investments S.A. Management Board based in Warsaw with (the Issuer), notifies of the merger of the Issuer’s subsidiaries, i.e. POLVENT spółka z ograniczoną odpowiedzialnością with its seat in Warsaw (“Acquired Company”) and TECHVIGO limited liability company with its seat…
NUTRIX – A NEW MEDTECH COMPANY IN OUR PARTNER’S PORTFOLIO
Another company joined the portfolio of our partner Carlson EVIG Alfa VC Fund. This time it is Nutrix, a Swiss medical technology startup that focuses on the development of software and artificial intelligence algorithms that help in monitoring glucose present…